Composition for delivery of toxic radioisotopes to the cell...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 51/10 (2006.01) A61K 47/48 (2006.01) A61K 51/08 (2006.01)

Patent

CA 2189051

A conjugate of a tumor cell-targeting protein or polypeptide and a nucleic acid-targeting small molecule labeled with an Auger electron-emitting radionuclide is useful for tumor therapy. The tumor cell-targeting protein or polypeptide may be an antibody or fragment thereof, a hormone or a growth factor.

Conjugué d'une protéine ou d'un polypeptide de ciblage de cellules tumorales et d'une petite molécule de ciblage de l'acide nucléique marquée à l'aide d'un radionucléide émettant des électrons Auger, utile dans la thérapie des tumeurs. Cette protéine ou ce polypeptide peut être un anticorps ou un fragment de celui-ci, une hormone ou un facteur de croissance.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Composition for delivery of toxic radioisotopes to the cell... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition for delivery of toxic radioisotopes to the cell..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for delivery of toxic radioisotopes to the cell... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1350901

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.